Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade

doi:10.4254/wjh.v7.i5.725

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12268)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

897

WORD

388

HTML

7455

Figures (1-1)

240

Tables (1-1)

211

Sum=9191

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1524

Download

1553

Sum=3077

Apr 18, 2015 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Apr 18, 2015; 7(5): 725-737
Published online Apr 18, 2015. doi: 10.4254/wjh.v7.i5.725

Open in New Tab Full Size Figure Download Figure

Figure 1 Milestones in hepatitis C virus basic research and treatment. HCV: Hepatitis C virus; DAA: Direct-acting antiviral; IFN: Interferons; IL28B: Interleukin-28B; RBV: Ribavirin; pegIFNα: Pegylated interferon-alpha.

Citation: Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 2015; 7(5): 725-737
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/725.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i5.725